Skip to main content
Clinical Trials/NCT04046588
NCT04046588
Unknown
Not Applicable

The Difference in Heat Transport Characteristics of the Heart and Lung Meridians: a Comparative Study of COPD Patients and Healthy Subjects

Zhejiang Chinese Medical University1 site in 1 country120 target enrollmentOctober 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Zhejiang Chinese Medical University
Enrollment
120
Locations
1
Primary Endpoint
Temperature change of relevant sites
Last Updated
6 years ago

Overview

Brief Summary

Although some important progresses were made in the field of the meridian research, no breakthroughs have been achieved. Besides,there are some problems in meridian researches. Particularly, previous research of meridian phenomenon involved lots of subjective elements and outcomes.Researches that use modern scientific techniques to investigate the biological characteristics of meridian phenomenon are urgently needed. Therefore, this study is designed to assess the heat transport characteristics of meridian phenomenon for the Heart and Lung meridians by using infrared thermography. Thus, the biological characteristics of meridian phenomenon could be presented objectively in a scientific methodology.

Detailed Description

This study will include 40 patients with chronic obstructive pulmonary disease (COPD) and 80 healthy adults. Infrared thermal imaging(ITI) examination will be adopted to assess the heat transport characteristics of the Heart and Lung meridians and investigate the specificity for the meridian-visceral correlation and site-to-site correlation between two specific meridians.

Registry
clinicaltrials.gov
Start Date
October 1, 2019
End Date
December 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Zhejiang Chinese Medical University
Responsible Party
Principal Investigator
Principal Investigator

Jianqiao Fang

President

Zhejiang Chinese Medical University

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for COPD
  • Patients should meet the above diagnostic criteria, and the severity of COPD is in the stage of GOLD 2 or 3 based on pulmonary function testing;
  • COPD patients in the stable phase, who present with mild symptoms of cough, expectoration and short breath;
  • 35 ≤ age ≤75 years, male or female;
  • Patients have clear consciousness and could communicate with others normally;
  • Patients could understand the full study protocol and have high adherence.Written informed consent is signed by themselves or their lineal kin.
  • Inclusion criteria for health volunteers
  • Healthy volunteers who could provide a recent medical examination report to confirm they have not any cardiovascular, respiratory, digestive, urinary, hematological, endocrine and neurological disease;
  • 35 ≤ age ≤75 years, male or female;
  • Participants have clear consciousness and could communicate with others normally;

Exclusion Criteria

  • Exclusion criteria for COPD
  • Patients who fail to meet the diagnostic criteria for COPD, or COPD patients in the phase of acute exacerbation;
  • Patients have the following complications, which includes pneumonia, bronchial asthma, bronchiectasis, active tuberculosis, pneumothorax, chest trauma, tumors of the lung or thorax, and other confirmed respiratory diseases;
  • Patients have concomitant conditions of heart diseases, such as chronic stable angina pectoris (CSAP);
  • Patients have serious concomitant conditions and fail to treat them effectively, such as diseases of the digestive, urinary, respiratory, hematological, and nervous system;
  • Patients have mental illness, severe depression, alcohol dependence or history of drug abuse;
  • Pregnant or lactating patients; Patients are participating in other trials.
  • Exclusion criteria of health volunteers
  • Participants have mental illness, severe depression, alcohol dependence or history of drug abuse;
  • Pregnant or lactating participants ;

Outcomes

Primary Outcomes

Temperature change of relevant sites

Time Frame: Baseline, 15 minutes during moxibustion, 5 minutes after stopping moxibustion

Infrared thermal imaging is used to record baseline temperature and the temperature change of corresponding sites along the Heart and Lung meridians.

Study Sites (1)

Loading locations...

Similar Trials